Totus Medicines

Series-B
totusmedicines.com Biotech & Healthcare Emeryville, United States Founded 2020 11–50 employees
Total Funding $106M
Latest Round $66M Series-B
Last Announced Dec 17, 2023
Investors 6 Backers
Decision Makers 6 Available

About Totus Medicines

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Emeryville, United States
Year Founded 2020
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website totusmedicines.com
Domain Registered Date Undisclosed

Social & Network Presence

LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $66,000,000 · Series-B

    Backed by DCVC Bio

  2. Capital Raise

    Raised $40,000,000 · Series-A

    Backed by DCVC Bio

  3. Milestone

    Company founded

    Emeryville, United States

Investors & Backers

6
DCVC Bio
Lead
Camford Capital
DHVC
Northpond Ventures
Regents of The University of Minnesota
Social Impact Capital

Funding History

2 Rounds
Series-B equity · Dec 17, 2023

Round backers: DCVC Bio

Series-A equity · Dec 1, 2021

Round backers: DCVC Bio

Founders & Leadership

7

Jason Pontin

Founder

Work email & phone locked Unlock →

Jimmy Blair

Founder

Work email & phone locked Unlock →

Laura Drum Miller

CBO and COO

Work email & phone locked Unlock →

Nassim Usman

President & CEO

Work email & phone locked Unlock →

Neil Dhawan

Founder

Work email & phone locked Unlock →

Simon Harnest

Chief Financial Officer

Work email & phone locked Unlock →

Zelanna Goldberg

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts